News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
766,254 Results
Type
Article (51441)
Company Profile (296)
Press Release (714501)
Multimedia
Podcasts (106)
Webinars (20)
Section
Business (212972)
Career Advice (2121)
Deals (36696)
Drug Delivery (135)
Drug Development (84107)
Employer Resources (174)
FDA (17304)
Job Trends (15834)
News (360944)
Policy (34935)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2821)
Accelerated approval (43)
Adcomms (30)
Allergies (171)
Alliances (51765)
ALS (205)
Alzheimer's disease (1825)
Antibody-drug conjugate (ADC) (430)
Approvals (17649)
Artificial intelligence (656)
Autoimmune disease (252)
Automation (53)
Bankruptcy (375)
Best Places to Work (12097)
BIOSECURE Act (20)
Biosimilars (212)
Biotechnology (190)
Bladder cancer (184)
Brain cancer (71)
Breast cancer (724)
Cancer (5676)
Cardiovascular disease (475)
Career advice (1806)
Career pathing (44)
CAR-T (314)
CDC (61)
Celiac Disease (2)
Cell therapy (833)
Cervical cancer (46)
Clinical research (72479)
Collaboration (2052)
Company closure (4)
Compensation (1325)
Complete response letters (78)
COVID-19 (2863)
CRISPR (102)
C-suite (1074)
Cystic fibrosis (150)
Data (7474)
Decentralized trials (3)
Denatured (38)
Depression (166)
Dermatology (71)
Diabetes (571)
Diagnostics (7102)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (309)
Drug pricing (206)
Drug shortages (34)
Duchenne muscular dystrophy (272)
Earnings (93424)
Editorial (68)
Employer branding (21)
Employer resources (153)
Events (124000)
Executive appointments (1079)
FDA (20942)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (34)
Funding (1703)
Gene editing (221)
Generative AI (62)
Gene therapy (679)
GLP-1 (1097)
Government (5001)
Grass and pollen (6)
Guidances (404)
Healthcare (20052)
HIV (78)
Huntington's disease (53)
IgA nephropathy (93)
Immunology and inflammation (284)
Immuno-oncology (88)
Indications (167)
Infectious disease (3204)
Inflammatory bowel disease (214)
Inflation Reduction Act (14)
Influenza (138)
Intellectual property (280)
Interviews (324)
IPO (17027)
IRA (51)
Job creations (4061)
Job search strategy (1509)
JPM (58)
Kidney cancer (18)
Labor market (94)
Layoffs (578)
Leadership (37)
Legal (8511)
Liver cancer (102)
Longevity (31)
Lung cancer (766)
Lymphoma (418)
Machine learning (57)
Management (59)
Manufacturing (982)
MASH (185)
Medical device (14919)
Medtech (15007)
Mergers & acquisitions (20873)
Metabolic disorders (1493)
mRNA (199)
Multiple sclerosis (181)
NASH (17)
Neurodegenerative disease (406)
Neuropsychiatric disorders (105)
Neuroscience (3308)
Neurotech (1)
NextGen: Class of 2026 (6922)
Non-profit (4786)
Now hiring (74)
Obesity (709)
Opinion (300)
Ovarian cancer (205)
Pain (248)
Pancreatic cancer (280)
Parkinson's disease (360)
Partnered (34)
Patents (570)
Patient recruitment (641)
Peanut (63)
People (62311)
Pharmaceutical (65)
Pharmacy benefit managers (33)
Phase 1 (22571)
Phase 2 (31836)
Phase 3 (23761)
Pipeline (7684)
Policy (317)
Postmarket research (2744)
Preclinical (9631)
Press Release (67)
Prostate cancer (291)
Psychedelics (53)
Radiopharmaceuticals (325)
Rare diseases (1045)
Real estate (6361)
Recruiting (70)
Regulatory (26645)
Reports (54)
Research institute (2576)
Resumes & cover letters (363)
Rett syndrome (34)
RNA editing (19)
RSV (91)
Schizophrenia (176)
Series A (279)
Series B (211)
Service/supplier (12)
Sickle cell disease (111)
Special edition (22)
Spinal muscular atrophy (169)
Sponsored (48)
Startups (3886)
State (2)
Stomach cancer (19)
Supply chain (131)
Tariffs (90)
The Weekly (66)
Vaccines (1123)
Venture capital (104)
Weight loss (471)
Women's health (119)
Worklife (20)
Date
Today (199)
Last 7 days (765)
Last 30 days (2823)
Last 365 days (31099)
2026 (9761)
2025 (30910)
2024 (36104)
2023 (41145)
2022 (52385)
2021 (57100)
2020 (55911)
2019 (48798)
2018 (36938)
2017 (33747)
2016 (33564)
2015 (39610)
2014 (33324)
2013 (28561)
2012 (30848)
2011 (31553)
2010 (29925)
Location
Africa (816)
Alabama (93)
Alaska (7)
Arizona (348)
Arkansas (16)
Asia (42790)
Australia (7055)
California (12724)
Canada (3638)
China (1329)
Colorado (557)
Connecticut (566)
Delaware (386)
Europe (93261)
Florida (1905)
Georgia (414)
Hawaii (3)
Idaho (66)
Illinois (1060)
India (87)
Indiana (587)
Iowa (23)
Japan (519)
Kansas (132)
Kentucky (49)
Louisiana (40)
Maine (75)
Maryland (1561)
Massachusetts (9153)
Michigan (362)
Minnesota (716)
Mississippi (7)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (142)
New Hampshire (90)
New Jersey (3403)
New Mexico (30)
New York (3361)
North Carolina (1684)
North Dakota (8)
Northern California (6314)
Ohio (377)
Oklahoma (24)
Oregon (42)
Pennsylvania (2568)
Puerto Rico (28)
Rhode Island (52)
South America (1201)
South Carolina (85)
South Dakota (2)
Southern California (5007)
Tennessee (207)
Texas (2030)
United States (45426)
Utah (381)
Vermont (1)
Virginia (304)
Washington D.C. (83)
Washington State (1050)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
766,254 Results for "blackstone medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug
March 4, 2026
·
6 min read
Funding
Teva Bags $400M Backing From Blackstone To Advance Sanofi-Partnered Drug
The funding comes weeks after TL1A blocker duvakitug maintained clinical remission rates above 50% in patients with ulcerative colitis and Crohn’s disease in a Phase 2b trial.
March 4, 2026
·
2 min read
·
Tristan Manalac
Venture capitalists
Blackstone Launches New $5B+ Fund for Life Sciences
Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.
January 31, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)
November 5, 2025
·
5 min read
Press Releases
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement
August 6, 2025
·
5 min read
Press Releases
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director
March 30, 2026
·
7 min read
Press Releases
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
April 6, 2026
·
1 min read
Press Releases
Avanos Medical, Inc. to Present at the 2026 Citizens Life Sciences Conference
March 3, 2026
·
1 min read
Business
Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program
Blackstone announced a new collaboration with Moderna, Inc. through a development and commercialization funding agreement where funds managed by Blackstone Life Sciences will provide up to $750 million to fund Moderna’s influenza program.
March 27, 2024
·
2 min read
Business
Blackstone Life Sciences Launches Uniquity Bio to Develop Novel Medicines in Immunology & Inflammation
Blackstone (NYSE:BX) today announced the launch of the Blackstone Life Sciences (“Blackstone”) portfolio company Uniquity Bio, a clinical-stage drug development company focused on immunology and inflammation.
May 15, 2024
·
5 min read
1 of 76,626
Next
